Author:
Nafziger J.,Guillosson J. J.,Adam Y.,Hecquet C.,Payard M.,Loiseau M.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology
Reference15 articles.
1. Andreani, A, Rambaldi, M, Andreani, F, Bossa, R and Galatulas, I (1988) Potential anti-tumor agents XVI. Imidazo (2, 1-b) thiazoles. Eur. J. Med. Chem. 23: 385?389.
2. Amarouch, H, Loiseau, PR, Bacha, C, Caujolle, R, Payard, M, Loiseau, PM, Bories, C and Gayral, P (1987) Imidazo (2, 1-b) thiazoles: analogues du levamisole. Eur. J. Med. Chem. 22: 463?466.
3. Amarouch, H, Loiseau, PR, Bonnafous, M, Caujolle, R and Payard, M (1988) Dihydro-5-6 imidazo (2, 1-b) thiazoles, dihydro-2, 3 imidazo (2, 1-b) benzothiazoles, analogues du levamisole. IL Farmaco 5: 421?437.
4. Bachur, NR, Egorin, MJ and Hildebrand, RC (1973) Daunorubicin and adriamycin metabolism in the golden syrian hamster. Biochem. Med. 8: 352?361.
5. Baguley, BC, Denny, WA, Atwell, GJ and Cain, BF (1981) Potential anti-tumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ring. J. Med. Chem. 24: 170?177.